The FDA on July 1, 2026, expanded Casgevy CRISPR gene therapy to children as young as 2 with sickle cell disease. Here is what families need to know about eligibility and access.
The World’s First CRISPR Gene Therapy Just Got Approved for Children as Young as 2 with Sickle Cell Disease
by | Jul 23, 2026 | Uncategorized | 0 comments
Recent Comments